BOTHELL, Wash., Oct. 18, 2017 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media, today announced that CEO Mike Rice and CFO Roderick de Greef will be attending and presenting at the following investor conferences:
- October 25th at 2:00PM; Cavendish Global New York Health Impact Forum. New York Athletic Club (City House); Session Title: Ground Breaking Discoveries and Innovations. For more information please visit http://cavendishglobal.com/2017-nyc/
- November 16th at 3:00PM; Furey Research Partners Hidden Gems Investor Conference. The University Club, New York. For more information please visit https://www.eventbrite.com/e/furey-research-partners-hidden-gems-conference-2017-tickets-38498157024?aff=erelexpmlt
- December 5th at 1:00PM; LD Micro 10th Annual Main Event. Luxe Sunset Boulevard Hotel, Los Angeles. For more information please visit https://www.ldmicro.com/events
About BioLife Solutions
BioLife Solutions is the leading developer, manufacturer and supplier of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media for cells and tissues. Our proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the regenerative medicine, biobanking and drug discovery markets. Our biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death; offering commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function.
Media & Investor Relations
Roderick de Greef
Chief Financial Officer
SOURCE BioLife Solutions, Inc.